Robot-Assisted Prostate Biopsy With a Novel Ultrasound Probe

Inclusion Criteria

• •Included in the study will be:
• •Men between the ages of 40 and 75
• •Men must have one of the following "high risk" features:
• •1. PSA \> 4.0 ng/ml and/or abnormal digital rectal examination (DRE)
• •2. ASAP (atypical small acinar proliferation) on previous biopsy
• •Men with mpMRI or bpMRI exams, including both PI-RADS ≤2 and PI-RADS ≥3.
• •Excluded from the study will be patients without available mpMRI exams and patients:
• •Females and children because of the prostate cancer targeted disease.
• •Patients who are not recommended or in whom TR or TP prostate biopsy is considered high-risk:
• •1. Patients with previous rectal surgery.
• •2. Patients with anal stenosis or coagulopathy.
• •3. Patients on active anticoagulation medication (eg. Coumadin, Lovenox, or Heparin).
• •4. Patients who cannot tolerate periprostatic Lidocaine block anesthesia or in whom anesthesia is considered high-risk.
• •Patients who already had a prostate biopsy taken with the ProBot investigational device.
• •Vulnerable populations, such as prisoners, institutionalized individuals.
• •Patients who are unwilling or unable to sign informed consent (no assent required).